OREXIGEN THERAPEUTICS INC - COM NEW (OREXQ)

CUSIP: 686164302

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / COM NEW
Total 13F shares
6,854,634
Share change
+1,202,954
Total reported value
$23,574,000
Put/Call ratio
165%
Price per share
$3.44
Number of holders
38
Value change
+$4,269,311
Number of buys
22
Number of sells
16

Quarterly Holders Quick Answers

What is CUSIP 686164302?
CUSIP 686164302 identifies OREXQ - OREXIGEN THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OREXIGEN THERAPEUTICS INC - COM NEW (OREXQ) as of Q1 2017

As of 31 Mar 2017, OREXIGEN THERAPEUTICS INC - COM NEW (OREXQ) was held by 38 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,854,634 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, BVF INC/IL, Foresite Capital Management II, LLC, VANGUARD GROUP INC, Foresite Capital Management III, LLC, NEA Management Company, LLC, GLG LLC, CREDIT SUISSE AG/, BlackRock Inc., and Old West Investment Management, LLC. This page lists 38 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.